121 related articles for article (PubMed ID: 30428652)
1. Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis.
Buja A; Sartor G; Scioni M; Girardi G; Vecchiato A; Bolzan M; Rebba V; Chiarion Sileni V; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
G Ital Dermatol Venereol; 2020 Dec; 155(6):764-771. PubMed ID: 30428652
[TBL] [Abstract][Full Text] [Related]
2. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines.
Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018
[TBL] [Abstract][Full Text] [Related]
3. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
5. Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education.
Buja A; Rivera M; Zorzi M; Sperotto M; Baracco S; Italiano I; Vecchiato A; Del Fiore P; Avossa F; Corti MC; Guzzinati S; Saia M; Baldo V; Rugge M; Rossi CR
Acta Derm Venereol; 2020 Jan; 100(1):adv00003. PubMed ID: 31580466
[No Abstract] [Full Text] [Related]
6. Quality management of cutaneous melanoma: impact on short-term outcomes and costs.
Buja A; De Luca G; Zorzi M; Carpin E; Pinato C; Vecchiato A; Del Fiore P; Bortolami A; Tognazzo S; Falasco F; Saia M; Baldo V; Rugge M; Rossi CR; Mocellin S
Eur J Dermatol; 2021 Dec; 31(6):730-735. PubMed ID: 34789442
[TBL] [Abstract][Full Text] [Related]
7. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Lyth J; Carstensen J; Synnerstad I; Lindholm C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
10. The cost of unresectable stage III or stage IV melanoma in Italy.
Maio M; Ascierto P; Testori A; Ridolfi R; Bajetta E; Queirolo P; Guida M; Romanini A; Chiarion-Sileni V; Pigozzo J; Di Giacomo AM; Calandriello M; Didoni G; van Baardewijk M; Konto C; Lucioni C
J Exp Clin Cancer Res; 2012 Nov; 31(1):91. PubMed ID: 23116062
[TBL] [Abstract][Full Text] [Related]
11. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
12. Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis.
Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
Actas Dermosifiliogr; 2017 Apr; 108(3):229-236. PubMed ID: 27887672
[TBL] [Abstract][Full Text] [Related]
13. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
14. An estimate of the annual direct cost of treating cutaneous melanoma.
Tsao H; Rogers GS; Sober AJ
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
[TBL] [Abstract][Full Text] [Related]
16. Early Cost-effectiveness Analysis of Electrochemotherapy as a Prospect Treatment Modality for Skin Melanoma.
Pirc E; Federici C; Bošnjak M; Perić B; Reberšek M; Pecchia L; Glumac N; Čemažar M; Snoj M; Serša G; Miklavčič D
Clin Ther; 2020 Aug; 42(8):1535-1548.e2. PubMed ID: 32768246
[TBL] [Abstract][Full Text] [Related]
17. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
[TBL] [Abstract][Full Text] [Related]
18. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
19. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
20. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
